On Valentines Day, BioSpace would be remiss not to mention, er, matters of the heart. There are reportedly 59 life sciences companies or organizations worldwide that focus on the cardiovascular system, ranging from the Aab Cardiovascular Research Institute based in West Henrietta, New York to XyloCor Therapeutics, headquartered in Philadelphia, Pennsylvania. That number is probably low.
But no matter how you look at it, there is a significant amount of work being done on cardiovascular diseases. Heres a look at just some of the recent news.
On January 28, 2020, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Companys Trijardy XR for lowering blood sugar in adults with type 2 diabetes.
Trijardy XR is a triple-combination pill that includes Jardiance (empagliflozin), Tradjenta (linagliptin) and metformin hydrochloride extended release. It is prescribed along with diet and exercise for decreasing blood glucose levels in type 2 diabetes.
In the U.S., Jardiance and Radjenta are once-daily tablet used to treat adults with type 2 diabetes. Jardiance has also been approved to decrease the risk of cardiovascular death in adults with type 2 diabetes with known cardiovascular disease.
On February 3, 2020, researchers with the University of South Florida (USF Health) identified key mechanisms behind the loss of capillaries, which drives numerous diseases, including high blood pressure, diabetes, malignant cancer and a variety of cardiovascular and neurodegenerative diseases.
Capillary regression (loss) is an underappreciated, yet profound, feature of many diseases, especially those affecting organs requiring a lot of oxygen to work properly, said George Davis, professor of molecular pharmacology and physiology at the USF Morsani College of Medicine in Tampa, Florida. If we know how blood vessels are altered or begin to break down, we should be able to fix it pharmacologically.
Davis led a research project that identified the three major proinflammatory mediators that drive capillary loss. They published the research in the journal Arteriosclerosis, Thrombosis, and Vascular Biology.
The mediators are interleukin-1 beta (IL-1), tumor necrosis factor alpha (TNFalpha) and thrombin). They found that individually and even more so when combined, these directly drive capillary regression. They also identified drug combinations that can neutralize antibodies that specifically block IL-1 and TNFalpha, that can interfere with this capillary loss.
On January 27, 2020, AstraZeneca announced that its Brilinta (ticagrelor) hit the primary endpoint in the Phase III THALES trial in stroke. The study showed that 90mg of Brilinta twice a day and taken with aspirin for 30 days, provided a statistically significant and clinically meaningful decrease in the risk of stroke and death compared to aspirin alone. The trial was run in more than 11,000 patients who had a minor acute ischemic stroke or high-risk transient ischemic attack (TIA) in 24 hours before the beginning of treatment.
Results of the Phase III THALES trial showed Brilinta, in combination with aspirin, improved outcomes in patients who had experienced a minor acute ischemic stroke or high-risk transient ischemic attack, said Mene Pangalos, executive vice president, BioPharmaceuticals R&D. We look forward to sharing the detailed result with health authorities.
Earlier that month, however, the company announced that after a recommendation from an independent Data Monitoring Committee, it was abandoning its Phase III STRENGTH trial for Epanova (omega-3 carboxylic acids) for mixed dyslipidemia (MDL). Epanova is a fish oil-derived combination of free fatty acids composed mostly of EPA and DHA. It was approved in the U.S. as an adjunct to diet to decrease triglyceride levels in adults with severe high triglycerides. That indication wasnt changed by the data from the STRENGTH trial.
AstraZenecas exit from the fish oil drug trial largely leaves Amarin Corporations Vascepa (icosapent ethyl) as the only fish-oil drug to not only treat high triglycerides, but to decrease the risk of first and subsequent heart attacks, strokes and heart problems. In its clinical trials, Vascepa decrease those risks by 30%.
Although derived from fish, Vascepa is not fish oil. It is made up of the omega-3 acid (EPA) in ethyl-ester form. It was designated a new chemical entity by the FDA,
The same day AstraZeneca made their announcement, another company in the market space, Acasti Pharma, also reported a failure. Its own fish oil-based candidate, CaPre (omega-3 phospholipid) for severe hypertriglyceridemia, announced topline data from its Phase III TRILOGY 1 trial. Although it reported a 30.5% median reduction in triglyceride levels compared to 27.5% in the placebo group at 12 weeks, as well as a 42.2% decrease in patients on background statins compared to 31.5%, because of an unexpectedly large placebo response, the trial did not reach statistical significance.
And as long as were belaboring the Matters of the Heart theme, in mid-December 2019, Vancouver, British Columbia-based Novoheart signed an exclusive licensing deal with Harvard Universitys Office of Technology Development.
The deal allows Novoheart to merge its MyHeart Platform with Harvards tissue-engineered scale model of the heart ventricle and bioreactor technology. Novoheart invented and commercialized the first and only human heart-in-a-jar model for drug discovery and development.
Harvards valved bioreactor technology was engineered in Kevin Kit Parkers laboratory. He is the Tarr Family Professor of Bioengineering and Applied Physics at Harvard A. Paulson School of Engineering and Applied Sciences.
The two institutions expect that the merged technology will result in a next-generation human heart-in-a-jar that will be a superior human heart model for disease modeling, drug discovery and development with unmatched biofidelity as well as significantly enhanced predictive accuracy, capacity and versatility.
In addition to developing various bioengineered human heart constructs, Novoheart wants to develop the technology into transplantable grafts for cell-based regenerative heart therapies. The companys various products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Tissue Strip (hvCTS), and Cardiac Organoid Chamber (hvCOC). It also offers consultation and screening and phenotyping services using its 2D or 3D tissue assays.
On November 26, Novoheart announced a collaboration with AstraZeneca to develop the worlds first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF). Working with AstraZenecas Cardiovascular, Renal and Metabolism team, they will initially establish a new in vitro model using Novohearts proprietary 3D human ventricular cardiac organoid chamber (hvCOC), also known as the human heart-in-a-jar.
Overall, we dont recommend buying your sweetheart a heart in a jar. Go with the classicschocolates or flowers, instead.
BioSpace source:
https://www.biospace.com/article/valentine-s-day-matters-of-the-heart-biopharma-style
See original here:
Valentine's Day Matters of the Heart, Biopharma-Style - PharmaLive
- Where is medical device approval headed? The horse's mouth speaks... [Last Updated On: August 17th, 2024] [Originally Added On: May 3rd, 2010]
- Starting a medical device company? You are better off without some of these "VC"s! [Last Updated On: August 17th, 2024] [Originally Added On: May 4th, 2010]
- Silicon Valley Business of Engineering - A great event and resource for local medical device folks and others... [Last Updated On: August 17th, 2024] [Originally Added On: May 5th, 2010]
- MedTech: A great bioscience resource for folks in New York [Last Updated On: August 17th, 2024] [Originally Added On: May 7th, 2010]
- Blog brief: Inventables - a nice resource for your medical device projects [Last Updated On: August 17th, 2024] [Originally Added On: May 17th, 2010]
- Want to help out a biotech hackerspace AND learn about medical device regulations? Come to my class... [Last Updated On: August 17th, 2024] [Originally Added On: June 8th, 2010]
- A prototyping tip & a quick update [Last Updated On: August 17th, 2024] [Originally Added On: August 2nd, 2010]
- The Healthcare bill of rights is here... [Last Updated On: August 17th, 2024] [Originally Added On: October 11th, 2010]
- Come join me for a workshop on "The Rules of Brainstorming" [Last Updated On: August 17th, 2024] [Originally Added On: October 11th, 2010]
- DIYBio gets a little more local...Bangalore just got one - is there one in your area? [Last Updated On: August 17th, 2024] [Originally Added On: November 7th, 2010]
- Are you an entrepreneur? A job seeker? Where are your major hurdles coming from? [Last Updated On: August 17th, 2024] [Originally Added On: November 28th, 2010]
- The World Diabetes Day is here [Last Updated On: August 17th, 2024] [Originally Added On: November 28th, 2010]
- Healthgamescamp, San Francisco is tomorrow, barcamps and more... [Last Updated On: August 17th, 2024] [Originally Added On: December 13th, 2010]
- Healthgamescamp - liveblog: "It's crazy and wild and fun" [Last Updated On: August 17th, 2024] [Originally Added On: December 13th, 2010]
- Healthgamescamp - liveblog; part 2 - break time! [Last Updated On: August 17th, 2024] [Originally Added On: December 13th, 2010]
- Quick Post: Are others (guests) allowed to post on this blog? [Last Updated On: August 17th, 2024] [Originally Added On: December 19th, 2010]
- Entrepreneurship Opportunities: The Health 2.0 challenge for 2011 is announced [Last Updated On: August 17th, 2024] [Originally Added On: December 19th, 2010]
- A heartwarming story, a foundation and a few medical device challenges for the future [Last Updated On: August 17th, 2024] [Originally Added On: December 27th, 2010]
- What will your 2011 medical device design resolutions be? [Last Updated On: August 17th, 2024] [Originally Added On: January 2nd, 2011]
- Elan was recently asked: Your workers or your private jet..guess what they chose? [Last Updated On: August 17th, 2024] [Originally Added On: February 6th, 2011]
- Blog Briefs: A great resource: The National Academies Press makes all pdf books free! [Last Updated On: August 17th, 2024] [Originally Added On: June 12th, 2011]
- On Scott Brown's unfactual rant... [Last Updated On: August 17th, 2024] [Originally Added On: June 26th, 2011]
- There's trouble ahead for Pharma... [Last Updated On: August 17th, 2024] [Originally Added On: July 3rd, 2011]
- The Acne Apps Scandal - how a select few make everyone suffer... [Last Updated On: August 17th, 2024] [Originally Added On: September 18th, 2011]
- Faculty Interview | MIT Introduction to Bioengineering, Spri [Last Updated On: August 17th, 2024] [Originally Added On: October 10th, 2011]
- Destroying Humanity with Social [Last Updated On: August 17th, 2024] [Originally Added On: October 10th, 2011]
- Bioengineering- Clemson Graduate School [Last Updated On: August 17th, 2024] [Originally Added On: October 10th, 2011]
- Faculty Interview | MIT Introduction to Bioengineering, Spri - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 13th, 2011]
- Grant to benefit Bioengineering research - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 14th, 2011]
- BioEngineering Associates, Inc. - Mad River Bluffs Stabilization Project - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 14th, 2011]
- BIO ENGINEERING - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 15th, 2011]
- Cross-Species Hybridization and Bioengineering: We're Not in Kansas Anymore! - Alex Jones Tv 2/2 - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 16th, 2011]
- Paul Root Wolpe: It's time to question bio-engineering - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 19th, 2011]
- BioEngineering Insights 2009 - BioMaterials Part 2 - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 22nd, 2011]
- Blog Action Day - Blogging for Food... [Last Updated On: August 17th, 2024] [Originally Added On: October 23rd, 2011]
- [KAIST-Bioengineering]Biomimetics - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 24th, 2011]
- [KAIST Bioengineering] Bioengineering through movies - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 26th, 2011]
- PhD Research in Belgium (Bioengineering at the University of Leuven) - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 29th, 2011]
- Penn Bioengineering: Modeling Contractile Forces - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 29th, 2011]
- Global 3000 | How One Bio-engineering Seed Producer is Dominating Markets - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 31st, 2011]
- White House Awards UC San Diego Bioengineering Professor Shu Chien National Medal of Science - Video [Last Updated On: August 17th, 2024] [Originally Added On: October 31st, 2011]
- [KAIST BioEngineering] Olleh! BioEng! - Video [Last Updated On: August 17th, 2024] [Originally Added On: November 9th, 2011]
- Calling BS on the link between tax increases and medical device innovation... [Last Updated On: August 17th, 2024] [Originally Added On: January 1st, 2012]
- Stanford's Stephen Quake, Bioengineer - Video [Last Updated On: August 17th, 2024] [Originally Added On: January 1st, 2012]
- Plandai Biotechnology, Inc. Announces Appointment of World-Renowned Physicist to Chair Plandai Scientific Board [Last Updated On: August 17th, 2024] [Originally Added On: January 30th, 2012]
- Need muscle for a tough spot? Turn to fat stem cells [Last Updated On: August 17th, 2024] [Originally Added On: January 31st, 2012]
- India gets her own stem cell hosptial [Last Updated On: August 17th, 2024] [Originally Added On: February 5th, 2012]
- A marketable major [Last Updated On: August 17th, 2024] [Originally Added On: February 7th, 2012]
- US Navy here to talk biofuels [Last Updated On: August 17th, 2024] [Originally Added On: February 7th, 2012]
- Carlsberg-invested Chongqing Brewery to hire independent auditors [Last Updated On: August 17th, 2024] [Originally Added On: February 7th, 2012]
- Industry linkage beefs up livestock nutrition [Last Updated On: August 17th, 2024] [Originally Added On: February 13th, 2012]
- The Hertz Foundation Selects 50 Finalists for 2012-2013 Hertz Fellowship Supporting Gifted Young Leaders in Applied ... [Last Updated On: August 17th, 2024] [Originally Added On: February 13th, 2012]
- US Navy eyes Aussie biofuel research [Last Updated On: August 17th, 2024] [Originally Added On: February 13th, 2012]
- Researchers make breakthrough in stem cell research [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2012]
- UQ researchers make breakthrough in stem cell research [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2012]
- Brand Marvel Worldwide Consumer Products Corporation Update [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2012]
- U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics in Order to Rapidly Find Solutions for ... [Last Updated On: August 17th, 2024] [Originally Added On: February 14th, 2012]
- Speaker to discuss Honor Code at UPUA meeting [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- Understand the Lessons Learned from the FDA QbD Pilot Programme - Case Study Merck Serono [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- Lewis: Fully caffeinated professor dreams up business [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- Titan Spine Acquires Additional Patent Protection for its Spinal Implant Surface Technologies [Last Updated On: August 17th, 2024] [Originally Added On: February 15th, 2012]
- Histogenics to Present at 7th Annual New York Stem Cell Summit [Last Updated On: August 17th, 2024] [Originally Added On: February 16th, 2012]
- Microchip successfully delivers bone-loss drug: study [Last Updated On: August 17th, 2024] [Originally Added On: February 16th, 2012]
- Microchip delivers drug; can it replace shots? [Last Updated On: August 17th, 2024] [Originally Added On: February 16th, 2012]
- Bioengineering company bringing ideas to Huntington [Last Updated On: August 17th, 2024] [Originally Added On: February 18th, 2012]
- UCLA Discovery that Migrating Cells "Turn Right' has Implications for Engineering Tissues, Organs [Last Updated On: August 17th, 2024] [Originally Added On: February 18th, 2012]
- After scrapping bigger plans, HP says webOS still has an open-source future [Last Updated On: August 17th, 2024] [Originally Added On: February 19th, 2012]
- Discovery that migrating cells 'turn right' has implications for engineering tissues, organs [Last Updated On: August 17th, 2024] [Originally Added On: February 19th, 2012]
- Biotechnology and Bioengineering: Cell stamping from PEG-oleyl surfaces - Video [Last Updated On: August 17th, 2024] [Originally Added On: February 21st, 2012]
- American Oriental Bioengineering Inc. Announces Plans for Reverse Stock Split of its Common Stock [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- Injectable gel could repair tissue damaged by heart attack [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- World’s First Lab-Engineered Burger Just Months Away [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- For UC Berkeley’s New Helios Energy Research Facility: Firespray’s Ductwork Solves Lab Construction Challenge [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- IBM and IBN Treating MRSA With Nanotechnology and Nanomedicine in February's Edition of Healthcare Global [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- Injectable gel could repair damaged cardiac tissue [Last Updated On: August 17th, 2024] [Originally Added On: February 22nd, 2012]
- DNA2.0 Partners with Cosmo Bio to Deliver Bioengineering Solutions to Japanese Researchers [Last Updated On: August 17th, 2024] [Originally Added On: February 23rd, 2012]
- Three UI professors win Sloan fellowships [Last Updated On: August 17th, 2024] [Originally Added On: February 23rd, 2012]
- IBM and IBN Treating MRSA with Nanotechnology and Nanomedicine in February’s Edition of Healthcare Global [Last Updated On: August 17th, 2024] [Originally Added On: February 23rd, 2012]
- Now, injectable gel that could repair tissue damaged by heart attack [Last Updated On: August 17th, 2024] [Originally Added On: February 23rd, 2012]
- India's drug discovery innovation prognosis is "poor". Is anyone surprised? [Last Updated On: August 17th, 2024] [Originally Added On: February 26th, 2012]